Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 190

1.

An extent of resection threshold for newly diagnosed glioblastomas.

Sanai N, Polley MY, McDermott MW, Parsa AT, Berger MS.

J Neurosurg. 2011 Jul;115(1):3-8. doi: 10.3171/2011.2.JNS10998. Epub 2011 Mar 18.

PMID:
21417701
2.

An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity.

Oppenlander ME, Wolf AB, Snyder LA, Bina R, Wilson JR, Coons SW, Ashby LS, Brachman D, Nakaji P, Porter RW, Smith KA, Spetzler RF, Sanai N.

J Neurosurg. 2014 Apr;120(4):846-53. doi: 10.3171/2013.12.JNS13184. Epub 2014 Jan 31.

PMID:
24484232
3.

Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma.

Grabowski MM, Recinos PF, Nowacki AS, Schroeder JL, Angelov L, Barnett GH, Vogelbaum MA.

J Neurosurg. 2014 Nov;121(5):1115-23. doi: 10.3171/2014.7.JNS132449. Epub 2014 Sep 5.

PMID:
25192475
4.

Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.

Bloch O, Han SJ, Cha S, Sun MZ, Aghi MK, McDermott MW, Berger MS, Parsa AT.

J Neurosurg. 2012 Dec;117(6):1032-8. doi: 10.3171/2012.9.JNS12504. Epub 2012 Oct 5.

PMID:
23039151
5.

The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?

Li YM, Suki D, Hess K, Sawaya R.

J Neurosurg. 2016 Apr;124(4):977-88. doi: 10.3171/2015.5.JNS142087. Epub 2015 Oct 23.

PMID:
26495941
6.

Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.

Marina O, Suh JH, Reddy CA, Barnett GH, Vogelbaum MA, Peereboom DM, Stevens GH, Elinzano H, Chao ST.

J Neurosurg. 2011 Aug;115(2):220-9. doi: 10.3171/2011.3.JNS10495. Epub 2011 May 6.

PMID:
21548745
7.

Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.

Niranjan A, Kano H, Iyer A, Kondziolka D, Flickinger JC, Lunsford LD.

J Neurosurg. 2015 Apr;122(4):757-65. doi: 10.3171/2014.11.JNS13295. Epub 2015 Jan 16.

PMID:
25594327
8.

Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.

Babu R, Komisarow JM, Agarwal VJ, Rahimpour S, Iyer A, Britt D, Karikari IO, Grossi PM, Thomas S, Friedman AH, Adamson C.

J Neurosurg. 2016 Apr;124(4):998-1007. doi: 10.3171/2015.4.JNS142200. Epub 2015 Oct 9.

PMID:
26452121
9.

When gross total resection of a glioblastoma is possible, how much resection should be achieved?

Chaichana KL, Cabrera-Aldana EE, Jusue-Torres I, Wijesekera O, Olivi A, Rahman M, Quinones-Hinojosa A.

World Neurosurg. 2014 Jul-Aug;82(1-2):e257-65. doi: 10.1016/j.wneu.2014.01.019. Epub 2014 Feb 6.

PMID:
24508595
10.

Glioblastoma surgery with and without intraoperative MRI at 3.0T.

Napolitano M, Vaz G, Lawson TM, Docquier MA, van Maanen A, Duprez T, Raftopoulos C.

Neurochirurgie. 2014 Aug;60(4):143-50. doi: 10.1016/j.neuchi.2014.03.010. Epub 2014 Jun 26.

11.

Volumetric Analysis Using Low-Field Intraoperative Magnetic Resonance Imaging for 168 Newly Diagnosed Supratentorial Glioblastomas: Effects of Extent of Resection and Residual Tumor Volume on Survival and Recurrence.

Fukui A, Muragaki Y, Saito T, Maruyama T, Nitta M, Ikuta S, Kawamata T.

World Neurosurg. 2017 Feb;98:73-80. doi: 10.1016/j.wneu.2016.10.109. Epub 2016 Oct 29.

PMID:
27989974
12.

Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance.

Kuhnt D, Becker A, Ganslandt O, Bauer M, Buchfelder M, Nimsky C.

Neuro Oncol. 2011 Dec;13(12):1339-48. doi: 10.1093/neuonc/nor133. Epub 2011 Sep 12. Erratum in: Neuro Oncol. 2014 Oct;16(10):1429.

13.

Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma.

Chaichana KL, Jusue-Torres I, Navarro-Ramirez R, Raza SM, Pascual-Gallego M, Ibrahim A, Hernandez-Hermann M, Gomez L, Ye X, Weingart JD, Olivi A, Blakeley J, Gallia GL, Lim M, Brem H, Quinones-Hinojosa A.

Neuro Oncol. 2014 Jan;16(1):113-22. doi: 10.1093/neuonc/not137. Epub 2013 Nov 26.

14.

A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival.

Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, Lang FF, McCutcheon IE, Hassenbusch SJ, Holland E, Hess K, Michael C, Miller D, Sawaya R.

J Neurosurg. 2001 Aug;95(2):190-8.

PMID:
11780887
15.

Extent of resection and radiotherapy in GBM: A 1973 to 2007 surveillance, epidemiology and end results analysis of 21,783 patients.

Zinn PO, Colen RR, Kasper EM, Burkhardt JK.

Int J Oncol. 2013 Mar;42(3):929-34. doi: 10.3892/ijo.2013.1770. Epub 2013 Jan 15.

PMID:
23338774
16.

Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: high-field iMRI versus conventional and 5-ALA-assisted surgery.

Roder C, Bisdas S, Ebner FH, Honegger J, Naegele T, Ernemann U, Tatagiba M.

Eur J Surg Oncol. 2014 Mar;40(3):297-304. doi: 10.1016/j.ejso.2013.11.022. Epub 2013 Dec 19.

PMID:
24411704
17.

Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme.

Prados MD, Wara WM, Sneed PK, McDermott M, Chang SM, Rabbitt J, Page M, Malec M, Davis RL, Gutin PH, Lamborn K, Wilson CB, Phillips TL, Larson DA.

Int J Radiat Oncol Biol Phys. 2001 Jan 1;49(1):71-7.

PMID:
11163499
18.

Extent of resection in patients with glioblastoma: limiting factors, perception of resectability, and effect on survival.

Orringer D, Lau D, Khatri S, Zamora-Berridi GJ, Zhang K, Wu C, Chaudhary N, Sagher O.

J Neurosurg. 2012 Nov;117(5):851-9. doi: 10.3171/2012.8.JNS12234. Epub 2012 Sep 14.

PMID:
22978537
19.
20.

Extent of resection of glioblastoma revisited: personalized survival modeling facilitates more accurate survival prediction and supports a maximum-safe-resection approach to surgery.

Marko NF, Weil RJ, Schroeder JL, Lang FF, Suki D, Sawaya RE.

J Clin Oncol. 2014 Mar 10;32(8):774-82. doi: 10.1200/JCO.2013.51.8886. Epub 2014 Feb 10.

Supplemental Content

Support Center